| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |